Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Can't wait to see CT get burned to the ground on this one. If he's so successful trading why does he spam every social media outlet and ticker with his 30 minute BS? I wouldn't join him if he paid me.
This is the exact evidence we need for the SEC to do something about the Marketmaker games. It's too bad they could give a rats azz about the OTC.
That was my buddy with the 800k he already bought at .07 200k. It took 48 fills to get that 800k.
Better than PRED
$$$$SBFM$$$ ZHUD$$$ NNDM $$$$
Anything is better than pred!
Next news uplist .50 to $1.00
Hopefully they can get this Covid pill through the trials then apply for EUA.
What a beautiful chart.
$$$$ dollar land coming no doubt in my mind. Onward and upward!
Why do people who got the vaccine still get covid?
Why do people who had covid get it again?
Do you want permanent lung damage?
More than 1/2 the population will not get a vaccine. Kids under 16 & 18 can't get a vaccine.
Wow you ask some really silly questions. Are you short and getting burned?
You can always buy it back.
Blue skys until $5 BUCKS!
Added more got another buddy in also.
I had no trouble buying ZHUD just getting through on the phone last week. gave up different issues.
I have Fidelity and was on hold for over 40 minutes tried again 30 minutes. Finally gave up. They're usually good. But during that GME fiasco couldn't get through.
Slow and easy let's hope for a steady climb. Unless of course some news hits and this soars!
Can you post what that says?
Yeah no doubt very lame.
otcmarkets.com click on Security details. Also click on disclosures for all filings.
I know what I own $75-$100 stock don't know when, but it's coming. 1st $25 End of March.
PRED=DEAD Someone put this company out of it's misery. Oh wait Brad needs a $300,000 a year salary.
Continued Research Grants New Options in Cancer Treatment
BY PR Newswire
— 9:00 AM ET 02/04/2021
NEW YORK, Feb. 4, 2021 /PRNewswire/ -- The growing prevalence of cancer all over the globe is a major obstacle to overcome. In 2020, an estimated 1,806,590 new cases of cancer were diagnosed in the United States alone and 606,520 people did not recover from the disease, according to cancer.gov. Additionally, estimated national expenditures for cancer care in the United States in 2018 were USD 150.8 Billion. However, costs are likely to increase as new, and often more expensive, treatments are adopted as standards of care. Overall, the global cancer therapeutics market is expected to grow at a CAGR of around 7.8% over the forecast period of 2019 to 2026 and reach the market value of over USD 176 Billion by 2026, according to a report by Acumen Research and Consulting. Sunshine Biopharma Inc. (OTC: SBFM), Cardiff Oncology, Inc. ( CRDF
Loading...
Loading...
) , Trillium Therapeutics Inc. ( TRIL
Loading...
Loading...
) , Surface Oncology, Inc. ( SURF ) , CytomX Therapeutics, Inc. ( CTMX
Loading...
Loading...
)
New technologies and innovation will play a major role in drug and therapeutics developments in the comping years. New startups which use Artificial Intelligence for drug discovery platforms and other technologies are also becoming more prevalent. For example, Forbes reported that Valo Health, which is developing a drug discovery platform powered by both artificial intelligence and large patient datasets, announced back in January that it's working on multiple targets that are implicated in different cancers.
Sunshine Biopharma Inc. (OTC: SBFM) announced earlier this week that, "it has received a "Notice of Allowance" from the Canadian Intellectual Property Office for a new patent application covering Adva-27a, the Company's flagship anticancer compound. This newly issued patent contains new subject matter and extends the proprietary protection of Adva-27a in Canada until 2033. The equivalent patent in the United States was issued in 2019 (US Patent Number 10,272,065) and similarly covers Adva-27a until 2033. The analogous patents are still pending in Europe. Sunshine Biopharma ( SBFM
Loading...
Loading...
) is the sole owner of all intellectual property rights pertaining to Adva-27a, including the first Adva-27a patent (US Patent Number 8,236,935) issued in 2012.
"We are very excited about this significant development for Adva-27a," said Dr. Steve N. Slilaty, CEO of Sunshine Biopharma ( SBFM
Loading...
Loading...
). "Allowance of this patent application gives us 12 years of additional protection and is a further validation of the uniqueness and innovative aspects of our lead anticancer molecule," he added.
About Sunshine Biopharma's ( SBFM
Loading...
Loading...
) Adva-27a: Adva-27a is a unique anticancer compound targeted for multidrug resistant cancer. Tests conducted to date have demonstrated the effectiveness of Adva-27a at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells, and Uterine Sarcoma cells. Clinical trials for Pancreatic Cancer indication are planned to be conducted at McGill University's Jewish General Hospital in Montreal, Canada
<$390 worth traded today!
Good morning all looks like a green open.
Aren't these guys supposed to merge with MMMM, PRED and BFNH? The NEW SYMBOL can BE S$ H$ I$ $T
Your crystal ball must be a good one.
Very transparent trying to bash to get cheap shares hilarious. Time to pay up.
What I said the other day endless supply of shares to dump. Notice the big predicted run into yesterday's close fizzled right out.
Pure HOG WASH! They don't have half the tools they do now. And it's still quite a challenge. They spend $BILLIONS researching cures for each type.
Now go take a nap in mommies basement.
That's the most ignorant thing I've heard so far on this thread.
This is for 2 new compounds NOT SBFM pl-4
What's the new contract details? How will they split the profits with the new compounds if they get approval?
Thanks the only turd here is the company and their management or more like lack of it. This was one giant scam.
Don't knock those Ford fairmonts that's what my dad drove LOL.
How long does the pill last? Is like a vitamin one a day?
What have you added? yeah nothing zero zilch! This stonk is dead money. Can't sell it, can't give it away. Can't move it. DEAD as MR. Wonderful says it's dead to me. A true POS.
I don't believe shorts are going anywhere. New rules will only screw the retail investor. Hopefully someone with some common sense gets to add their .02 for the retail investors. Glad to see the lawsuit naming all the crooks who stopped trading in gme etc etc.
I can deal with $2-$5~
The seller is back at it!
Carlsquare M&A experts already introduced them to several companies.
I think they will be doing a cash and stock offer. What better incentive to entice the workers to perform?
That's the real question because without the final approval. It may have a good run, but for real money it has to get FDA approval.
They keep coming out with vaccines now Astra Zeneca just came out with a new one.
Will it dawrf abml from .10 to 4.90? I sure hope so!
Like I said yesterday these sellers seem to have unlimited shares. Who the hell shorts a .13 stock? Max gain .13 max loss unlimited. The crooks at robbinghood limiting shares and stopping buying should be in prison.